Clinical Trial Update: The Efficacy of Transarterial Chemoinfusion (TAI) Combine Lenvatinib in Advanced Hepatocellular Carcinoma (HCC) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating transarterial chemoinfusion (TAI) combined with lenvatinib in advanced hepatocellular carcinoma is reported as ongoing with unknown sta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Lenvatinib (lenvatinib)
• transarterial chemoinfusion (transarterial chemoinfusion)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Hepatocellular Carcinoma | Phase 3 | Status: UNKNOWN